Shanghai Runda Med Tech Co (603108) - Total Assets
Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) holds total assets worth CN¥13.79 Billion CNY (≈ $2.02 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai Runda Med Tech Co - Total Assets Trend (2014–2024)
This chart illustrates how Shanghai Runda Med Tech Co's total assets have evolved over time, based on quarterly financial data. Also see how much is Shanghai Runda Med Tech Co worth for the company's overall valuation and market capitalisation.
Shanghai Runda Med Tech Co - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Runda Med Tech Co's total assets of CN¥13.79 Billion consist of 64.3% current assets and 35.7% non-current assets. Review debt load of Shanghai Runda Med Tech Co to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 8.4% |
| Accounts Receivable | CN¥5.20 Billion | 36.3% |
| Inventory | CN¥1.32 Billion | 9.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥97.00 Million | 0.7% |
| Goodwill | CN¥1.98 Billion | 13.9% |
Asset Composition Trend (2014–2024)
This chart illustrates how Shanghai Runda Med Tech Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 603108 share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Runda Med Tech Co's current assets represent 64.3% of total assets in 2024, an increase from 0.0% in 2014.
- Cash Position: Cash and equivalents constituted 8.4% of total assets in 2024, down from 12.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 2.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 36.3% of total assets.
Shanghai Runda Med Tech Co Competitors by Total Assets
Key competitors of Shanghai Runda Med Tech Co based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
|
Prodia Widyahusada Tbk PT
JK:PRDA
|
Indonesia | Rp2.57 Trillion |
|
RHYTHM Biosciences Ltd
AU:RHY
|
Australia | AU$3.10 Million |
|
Check Cap Ltd
NASDAQ:CHEK
|
USA | $377.00K |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$512.35 Million |
Shanghai Runda Med Tech Co - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 1.22 | 1.12 |
| Quick Ratio | 1.00 | 1.05 | 0.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.50 Billion | CN¥1.74 Billion | CN¥644.33 Million |
Shanghai Runda Med Tech Co - Advanced Valuation Insights
This section examines the relationship between Shanghai Runda Med Tech Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.33 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | CN¥14.31 Billion |
| Market Capitalization | $898.38 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Runda Med Tech Co's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shanghai Runda Med Tech Co's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shanghai Runda Med Tech Co (2014–2024)
The table below shows the annual total assets of Shanghai Runda Med Tech Co from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥14.31 Billion ≈ $2.09 Billion |
-0.03% |
| 2023-12-31 | CN¥14.31 Billion ≈ $2.09 Billion |
-1.44% |
| 2022-12-31 | CN¥14.52 Billion ≈ $2.12 Billion |
+20.82% |
| 2021-12-31 | CN¥12.02 Billion ≈ $1.76 Billion |
+18.08% |
| 2020-12-31 | CN¥10.18 Billion ≈ $1.49 Billion |
+12.66% |
| 2019-12-31 | CN¥9.03 Billion ≈ $1.32 Billion |
+19.75% |
| 2018-12-31 | CN¥7.54 Billion ≈ $1.10 Billion |
+5.86% |
| 2017-12-31 | CN¥7.13 Billion ≈ $1.04 Billion |
+73.45% |
| 2016-12-31 | CN¥4.11 Billion ≈ $601.12 Million |
+142.53% |
| 2015-12-31 | CN¥1.69 Billion ≈ $247.86 Million |
+56.13% |
| 2014-12-31 | CN¥1.08 Billion ≈ $158.75 Million |
-- |
About Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more